INS and diabetes mellitus: For example, in the treatment of diabetes mellitus with long-acting insulin, product shifts to the higher concentrated insulin glargine formulation Toujeo® [300 U/ml compared to the traditional formulation of 100 U/ml (reference product Lantus® and biosimilar Abasaglar®)] or insulin degludec (Tresiba®) were mentioned.